These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 10604379

  • 21. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J.
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [Abstract] [Full Text] [Related]

  • 22. Effect of intravesical instillation on performance of uCYT+ test.
    Lodde M, Mian C, Negri G, Vittadello F, Comploj E, Palermo S, Staffler A, Brössner C, Pycha A.
    Urology; 2004 May; 63(5):878-81. PubMed ID: 15134970
    [Abstract] [Full Text] [Related]

  • 23. Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells.
    Morcos E, Jansson OT, Adolfsson J, Ehrén I, Wiklund NP.
    J Urol; 2001 Feb; 165(2):678-82. PubMed ID: 11176457
    [Abstract] [Full Text] [Related]

  • 24. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
    Uchida A, Yonou H, Hayashi E, Iha K, Oda M, Miyazato M, Oshiro Y, Hokama S, Sugaya K, Ogawa Y.
    Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
    [Abstract] [Full Text] [Related]

  • 25. Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG.
    Sanchez-Carbayo M, Urrutia M, Romani R, Herrero M, Gonzalez de Buitrago JM, Navajo JA.
    Anticancer Res; 2001 Feb; 21(4B):3041-7. PubMed ID: 11712808
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of patients with recurrent superficial bladder cancer with lyophilized Moureau-Rio de Janeiro BCG strain. Brazillian National Cancer Institute experience].
    Quirino R, Ornellas AA, Wisnescky A.
    Prog Urol; 2005 Sep; 15(4):667-73. PubMed ID: 16459683
    [Abstract] [Full Text] [Related]

  • 27. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men.
    Haack M, Reichenberg A, Kraus T, Schuld A, Yirmiya R, Pollmächer T.
    Cytokine; 2000 Jun; 12(6):694-8. PubMed ID: 10843747
    [Abstract] [Full Text] [Related]

  • 28. Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy.
    Chang SG, Lee SJ, Huh JS, Lee JH.
    Oncol Rep; 2001 Jun; 8(2):257-61. PubMed ID: 11182036
    [Abstract] [Full Text] [Related]

  • 29. [Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin].
    Shimasaki N, Yamasaki I, Kamada M, Syuin T.
    Hinyokika Kiyo; 2001 Apr; 47(4):281-4. PubMed ID: 11411106
    [Abstract] [Full Text] [Related]

  • 30. BCG dose reduction by decreasing the instillation frequency: effects on local Th1/Th2 cytokine responses in a mouse model.
    de Boer EC, Rooyakkers SJ, Schamhart DH, de Reijke TM, Kurth KH.
    Eur Urol; 2005 Aug; 48(2):333-8. PubMed ID: 15963631
    [Abstract] [Full Text] [Related]

  • 31. The fate of bacillus Calmette-Guerin after intravesical instillation.
    Durek C, Richter E, Basteck A, Rüsch-Gerdes S, Gerdes J, Jocham D, Böhle A.
    J Urol; 2001 May; 165(5):1765-8. PubMed ID: 11342972
    [Abstract] [Full Text] [Related]

  • 32. The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy.
    Joudi FN, Smith BJ, O'Donnell MA, Konety BR.
    J Urol; 2006 May; 175(5):1634-9; discussion 1639-40. PubMed ID: 16600718
    [Abstract] [Full Text] [Related]

  • 33. Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.
    Poppas DP, Pavlovich CP, Folkman J, Voest EE, Chen X, Luster AD, O'Donnell MA.
    Urology; 1998 Aug; 52(2):268-75; discussion 275-6. PubMed ID: 9697793
    [Abstract] [Full Text] [Related]

  • 34. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K, Chihara Y, Kondo H, Hirao Y.
    Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
    [Abstract] [Full Text] [Related]

  • 35. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
    Peyromaure M, Guerin F, Amsellem-Ouazana D, Saighi D, Debre B, Zerbib M.
    J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of bacillus Calmette-Guérin in the treatment of superficial bladder cancer: the impact of previous intravesical treatment.
    Okamura T, Akita H, Imura M, Kaneko T, Mizuno K, Tozawa K, Kohri K.
    Int J Urol; 2008 Oct; 15(11):976-80. PubMed ID: 18721199
    [Abstract] [Full Text] [Related]

  • 37. Low dose BCG as adjuvant therapy for superficial bladder cancer and literature review.
    Cheng CW, Ng MT, Chan SY, Sun WH.
    ANZ J Surg; 2004 Jul; 74(7):569-72. PubMed ID: 15230793
    [Abstract] [Full Text] [Related]

  • 38. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H.
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [Abstract] [Full Text] [Related]

  • 39. Effects of intravesical chemotherapy and immunotherapy on semen analysis.
    Raviv G, Pinthus JH, Shefi S, Mor Y, Kaufman-Francis K, Levron J, Weissenberg R, Ramon J, Madgar I.
    Urology; 2005 Apr; 65(4):765-7. PubMed ID: 15833524
    [Abstract] [Full Text] [Related]

  • 40. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y, Oogo Y, Takase K, Hamano A, Yamashita Y, Noguchi S, Satomi Y.
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.